Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE HEALTH — Investor Presentation (September 2021)
20 slides from Scienture's investor presentation, Sep 9, 2021
Slide 1: Digitalizing the Retail Pharmacy Experience
Digitalizing the Retail, Pharmacy Experience ~ . » Investor Presentation August 2021
Slide 2: Safe Harbor Statement
Safe Harbor Statement ‘The information set forth herein contains forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts, including, but not limited to, statements regarding future ‘operations, financial results, cash flo
Slide 3: About TRxADE HEALTH, INC.
About TRXADE HEALTH, INC. TRXADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. * Market Leader: Operates one of the largest technology platfor
Slide 4: Divisions of TRxADE HEALTH
Divisions of TRXADE HEALTH Platform Company with Various B2B + B2C Subsidiaries! @ a MEDCHEKS (Health Passport) Ka @rRp0e Marketplace Platform HEALTH Drown (TeleHealth) PHARMA SOLUTIONS, (Rx Distributor) COMMUNITY SPECIALTY PHARMACY (Pharmacy) “Innovation Lab” (Technology Bridge) 1) Pie slices not r
Slide 5: TRxADE Marketplace
TRxADE Marketplace Independent Pharmacy Our B2B Pharmaceutical Supply Chain Platform Nationwide Footprint U.S. Pharmaceutical Industry! Growth TRxADE * Projected $685B per year industry size by 2023 and growing; Over 65,000 Opportunity Registered pharmacy facilities Users * Approximately 9 out of 10
Slide 6: TRxADE Marketplace
TRxADE Marketplace Our B2B Pharmaceutical Supply Chain Platform Our Marketplace Solution * TRXADE’s exchange platform offers a clear and concise interface that allows registered independent pharmacies to analyze “up-to-the-minute” supply & pricing from multiple pharma suppliers * Economies of scale
Slide 7: Bonum Health
HEALTH Bonum Health ¢ BONUM Patient Centric Telehealth Services Access to Board-Certified Providers & Health Assessment Tools from Anywhere Individually or through an employer sponsored program, patients can access board-certified medical providers nationwide using the Bonum Health mobile app and we
Slide 8: Healthcare Infrastructure
Healthcare Infrastructure Pharmacy & Wholesale Divisions Broaden Capabilities PHARMA SC Integra Pharma Solutions Integra Pharma Solutions is the pharmaceutical supplier of choice for healthcare organizations of all sizes. The Company's expertise in the distribution of products extends to all healthc
Slide 9: MedCheks Digital Health Passport
MedCheks Digital Health Passport Secure Display of Vaccination & COVID-19 Test Result Status The MedCheks Health Passport, currently in development, will store an individual’s health records safely in one place leveraging state-of-the-art encryption & blockchain technology, allowing the holder to se
Slide 10: Tomorrow's Digital Health Services Opportunity
10 Tomorrow’s Digital Health Services Opportunity Current Pharmacy Services Landscape Non-Insurance based technology providers * GoodRx + RO * Hims + Phil New Age Digital Pharmacies * Amazon-PillPak * Alto Pharmacy * Capsule * Nimble * HealthWarehouse * True Pill Logistic Providers * ScriptDrop * Ub
Slide 11: TRxADE's Opportunity
11 TRxADE’s Opportunity The Opportunity Digitally unify brick and mortar retail pharmacies to deliver exceptional patient-centric health services We believe the industry needs: A true partner with experience and resources to create complex bridges between fragmented healthcare services to drive coor
Slide 12: TRxADE's Future Vision: A Digital Health Services Ecosystem
12 TRxADE’s Future Vision: A Digital Health Services Ecosystem* Goal to Create a Trusted Technology Platform Delivering Exceptional Patient Health Outcomes Telemedicine Telepharmacy Digital Health Passport Access to a_ licensed physician Access to a licensed network pharmacist | Comprehensive digita
Slide 13: TRxADE Industry Comparable Companies
123 TRxADE Industry Comparable Companies! Valuation? Category: Prescription Amerisource (Good Neighbor Pharmacy) $258 Pharmacy Comps - TRxADE $41m Secondary Marketplace Distribution (B2B) Primary Supplier RARER McKesson (Healthmart) $318 Primary Supplier Cardinal (Leader) $15B Primary Supplier Categ
Slide 14: Selected Financials
Selected Financials * High Margin: Revenue from transaction fees on marketplace platform (Credit Card/PayPal model) does not include the drugs value (over $100M annually), hence “tech like margins” * Built-Out Platform: 12,700+ registered members with continued platform development requiring minimal
Slide 15: Management
Management \ Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Aijarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of Trxade Group, Inc., a Nevada corporation ("TRXADE Nevada”) (our predecessor company) on January 8, 2014, and
Slide 16: Key Takeaways
16 Key Takeaways NASDAQ:MEDS TRxADE is a technology-enabled health services platform company focused on digitalizing Annual Revenue Growth (USDSin Thousands) $17,122 the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. A Tech Focu
Slide 17: Investor Relations Contact
17 Investor Relations Contact Lucas A. Zimmerman Director MZ North America Main: 949-259-4987 MEDS@mzgroup.us www.mzgroup.us Contact Us TRxADE HEALTH, INC. 3840 Land O' Lakes Boulevard Land O'Lakes, FL 34639 (800) 261-0281 www.trxadehealth.com (TRADE www.trxade.com www.rxintegra.com www.bonumhealth.
Slide 18: Appendix: Consolidated Balance Sheet
Appendix: mous, ‘Jane 30, 2021, and December 31, 2020 (anaudted) A December 3, Consolidated Balance Sheet ho June 30,2021 "000 i Current Asets Can Ss 45998 8 sage Sees Race ut tne ‘oss = reat ues Pepe deer Boo iSite Oar Recess utetans otal Caent Aes SHeIe San 98 Property Plan and Equipment, Net 1300
Slide 19: Appendix: Consolidated Statements of Operations
Appendix: Consolidated Statements of Operations ‘TRxADE HEALTH, INC. ‘Consolidated Statements of Operations For the Three and Six Months Ended June 30, 2021, and 2020 (unaudited) ‘Three months ended Six months ended 2021 2020 2021 2020 Revenues S 1,898,254 6,592,637 «4,951,489 8,795,957 Cost of Sale
Slide 20: Appendix: Reconciliation of Net Income to Adj. EBITDA
Appendix: Reconciliation of Net Income to Adj. EBITDA! Reconciliation of Net Income (Loss) attributable to TRtADE HEALTH, INC., to Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) and Adjusted EBITDA* For the three months ended _—_—For the six months ended Sune 30, Sune 30, 20
TRxADE HEALTH — Investor Presentation (September 2021) on 6ix